Feasibility of combination allogeneic stem cell therapy for spinal cord injury: A case report

International Archives of Medicine

Volumn 3, Issue 1, 2010, Pages

  Ichim, Thomas E ^a   Solano, Fabio ^b   Lara, Fabian ^b   Paris, Eugenia ^c   Ugalde, Federico ^b   Rodriguez, Jorge Paz ^b   Minev, Boris ^d   Bogin, Vladimir ^a,e   Ramos, Famela ^a   Woods, Erik J ^f   Murphy, Michael P ^g   Patel, Amit N ^h   Harman, Robert J ⁱ   Riordan, Neil H ^a  

^a Medistem Inc   (United States)

^b Medistem Panama City of Knowledge   (Panama)

^c Hospital CIMA   (Costa Rica)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Cromos Pharma Services   (United States)

^f General Biotechnology   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ Vet Stem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADIPOSE TISSUE CELL; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; INTESTINE FUNCTION; MALE; MUSCLE FUNCTION; NEUROPATHIC PAIN; NONHUMAN; OLFACTORY ENSHEATHING CELL; PAIN ASSESSMENT; SCHWANN CELL; SCORING SYSTEM; SENSORIMOTOR FUNCTION; SEXUAL FUNCTION; SPINAL CORD INJURY; UMBILICAL CORD BLOOD; VERTEBRA BODY; VISUAL ANALOG SCALE;

EID: 78149352217     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-3-30     Document Type: Article

References (116)

1. A review of published reports on neuroprotection in spinal cord injury. G Onose A Anghelescu DF Muresanu L Padure MA Haras CO Chendreanu LV Onose A Mirea AV Ciurea WS El Masri KR von Wild, Spinal Cord 2009 47 716 726 10.1038/sc.2009.52 19597522
2. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. LF Geffner P Santacruz M Izurieta L Flor B Maldonado AH Auad X Montenegro R Gonzalez F Silva, Cell Transplant 2008 17 1277 1293 10.3727/096368908787648074 19364066
3. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. E Sykova A Homola R Mazanec H Lachmann SL Konradova P Kobylka R Padr J Neuwirth V Komrska V Vavra J Stulik M Bojar, Cell Transplant 2006 15 675 687 10.3727/000000006783464381 17269439
4. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. SH Yoon YS Shim YH Park JK Chung JH Nam MO Kim HC Park SR Park BH Min EY Kim BH Choi H Park Y Ha, Stem Cells 2007 25 2066 2073 10.1634/stemcells.2006-0807 17464087
5. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. C Lima J Pratas-Vital P Escada A Hasse-Ferreira C Capucho JD Peduzzi, J Spinal Cord Med 2006 29 191 203 discussion 204-196 16859223
6. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. A Mackay-Sim F Feron J Cochrane L Bassingthwaighte C Bayliss W Davies P Fronek C Gray G Kerr P Licina A Nowitzke C Perry PA Silburn S Urquhart T Geraghty, Brain 2008 131 2376 2386 10.1093/brain/awn173 18689435
7. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. H Saberi P Moshayedi HR Aghayan B Arjmand SK Hosseini SH Emami-Razavi V Rahimi-Movaghar M Raza M Firouzi, Neurosci Lett 2008 443 46 50 10.1016/j.neulet.2008.07.041 18662744
8. Decrescito Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. AR Blight, Neuroscience 1986 19 321 341 10.1016/0306-4522(86)90025-4 3785669
9. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. R Nashmi MG Fehlings, Neuroscience 2001 104 235 251 10.1016/S0306-4522(01)00009-4 11311546
10. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. MJ Crowe JC Bresnahan SL Shuman JN Masters MS Beattie, Nat Med 1997 3 73 76 10.1038/nm0197-73 8986744
11. Studies of myelin formation after transplantation of human Schwann cells into the severe combined immunodeficient mouse. AD Levi RP Bunge, Exp Neurol 1994 130 41 52 10.1006/exnr.1994.1183 7821395
12. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. S Casha WR Yu MG Fehlings, Neuroscience 2001 103 203 218 10.1016/S0306-4522(00) 00538-8 11311801
13. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. S Casha WR Yu MG Fehlings, Exp Neurol 2005 196 390 400 10.1016/j.expneurol.2005.08.020 16202410
14. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. A Ackery S Robins MG Fehlings, J Neurotrauma 2006 23 604 616 10.1089/neu.2006.23.604 16689665
15. Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. VR Dasari DG Spomar L Li M Gujrati JS Rao DH Dinh, Neurochem Res 2008 33 134 149 10.1007/s11064-007-9426-6 17703359
16. Excitatory amino acids as a final common pathway for neurologic disorders. SA Lipton PA Rosenberg, N Engl J Med 1994 330 613 622 10.1056/NEJM199403033300907 7905600
17. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. W Peng ML Cotrina X Han H Yu L Bekar L Blum T Takano GF Tian SA Goldman M Nedergaard, Proc Natl Acad Sci USA 2009 106 12489 12493 10.1073/pnas.0902531106 19666625
18. P2X7 receptor inhibition improves recovery after spinal cord injury. X Wang G Arcuino T Takano J Lin WG Peng P Wan P Li Q Xu QS Liu SA Goldman M Nedergaard, Nat Med 2004 10 821 827 10.1038/nm1082 15258577
19. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. E Park AA Velumian MG Fehlings, J Neurotrauma 2004 21 754 774 10.1089/ 0897715041269641 15253803
20. Effect of 4-aminopyridine in acute spinal cord injury. SS Haghighi SL Pugh MA Perez-Espejo JJ Oro, Surg Neurol 1995 43 443 447 10.1016/0090-3019(95) 80087-W 7660281
21. 4-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in rats. JA Gruner AK Yee, Brain Res 1999 816 446 456 10.1016/S0006-8993(98)01184-6 9878868
22. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. AR Blight JP Toombs MS Bauer WR Widmer, J Neurotrauma 1991 8 103 119 10.1089/neu.1991.8.103 1870134
23. Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial. I Grijalva G Guizar-Sahagun G Castaneda-Hernandez D Mino H Maldonado-Julian G Vidal-Cantu A Ibarra O Serra H Salgado-Ceballos R Arenas-Hernandez, Pharmacotherapy 2003 23 823 834 10.1592/phco.23.7.823.32731 12885095
24. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial. JL Segal MS Pathak JP Hernandez PL Himber SR Brunnemann RS Charter, Pharmacotherapy 1999 19 713 723 10.1592/phco.19.9.713. 31540 10391417
25. 4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injury. JL Segal SR Brunnemann, Pharmacotherapy 1997 17 415 423 9165545
26. Degenerative and spontaneous regenerative processes after spinal cord injury. T Hagg M Oudega, J Neurotrauma 2006 23 264 280 16629615
27. An electron microscopic analysis of abnormal ependymal cell proliferation and envelopment of sprouting axons following spinal cord transection in the rat. MA Matthews MF St Onge CL Faciane, Acta Neuropathol 1979 45 27 36 10.1007/BF00691801 760363
28. Ependymal development, proliferation, and functions: a review. JE Bruni, Microsc Res Tech 1998 41 2 13 10.1002/(SICI)1097-0029(19980401)41:1<2::AID- JEMT2>3.0.CO;2-Z 9550133
29. Response of ependymal progenitors to spinal cord injury or enhanced physical activity in adult rat. D Cizkova M Nagyova L Slovinska I Novotna J Radonak M Cizek E Mechirova Z Tomori J Hlucilova J Motlik I Sulla Jr I Vanicky, Cell Mol Neurobiol 2009 29 999 1013 10.1007/s10571-009-9387-1 19350385
30. Activated spinal cord ependymal stem cells rescue neurological function. V Moreno-Manzano FJ Rodriguez-Jimenez M Garcia-Rosello S Lainez S Erceg MT Calvo M Ronaghi M Lloret R Planells-Cases JM Sanchez-Puelles M Stojkovic, Stem Cells 2009 27 733 743 10.1002/stem.24 19259940
31. Spinal cord injury reveals multilineage differentiation of ependymal cells. K Meletis F Barnabe-Heider M Carlen E Evergren N Tomilin O Shupliakov J Frisen, PLoS Biol 2008 6 182 10.1371/journal.pbio.0060182 18651793
32. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. MC Jimenez Hamann CH Tator MS Shoichet, Exp Neurol 2005 194 106 119 10.1016/j.expneurol.2005.01.030 15899248
33. FGF-2-treatment improves locomotor function via axonal regeneration in the transected rat spinal cord. S Furukawa Y Furukawa, Brain Nerve 2007 59 1333 1339 18095482
34. Inhibitors of neurite growth. ME Schwab JP Kapfhammer CE Bandtlow, Annu Rev Neurosci 1993 16 565 595 10.1146/annurev.ne.16.030193.003025 7681638
35. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. BP Liu A Fournier T GrandPre SM Strittmatter, Science 2002 297 1190 1193 10.1126/science.1073031 12089450
36. Nogo-66 receptor antagonist peptide promotes axonal regeneration. T GrandPre S Li SM Strittmatter, Nature 2002 417 547 551 10.1038/417547a 12037567
37. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. LL Jones RU Margolis MH Tuszynski, Exp Neurol 2003 182 399 411 10.1016/S0014-4886(03)00087- 6 12895450
38. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. A Buss K Pech BA Kakulas D Martin J Schoenen J Noth GA Brook, BMC Neurol 2009 9 32 10.1186/1471-2377-9-32 19604403
39. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. RJ McKeon RC Schreiber JS Rudge J Silver, J Neurosci 1991 11 3398 3411 1719160
40. Chondroitinase ABC promotes corticospinal axon growth in organotypic cocultures. T Nakamae N Tanaka K Nakanishi N Kamei H Sasaki T Hamasaki K Yamada R Yamamoto Y Mochizuki M Ochi, Spinal Cord 2009 47 161 165 10.1038/sc.2008.74 18542086
41. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. NJ Tester DR Howland, Exp Neurol 2008 209 483 496 10.1016/j.expneurol.2007.07.019 17936753
42. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. G Garcia-Alias S Barkhuysen M Buckle JW Fawcett, Nat Neurosci 2009 12 1145 1151 10.1038/nn.2377 19668200
43. Modeling the neurovascular niche: implications for recovery from CNS injury. JA Madri, J Physiol Pharmacol 2009 60 Suppl 4 95 104 20083857
44. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. A Taguchi T Soma H Tanaka T Kanda H Nishimura H Yoshikawa Y Tsukamoto H Iso Y Fujimori DM Stern H Naritomi T Matsuyama, J Clin Invest 2004 114 330 338 15286799
45. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. HM Kim DH Hwang JE Lee SU Kim BG Kim, PLoS One 2009 4 4987 10.1371/journal.pone. 0004987 19319198
46. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. H Sasaki M Ishikawa N Tanaka K Nakanishi N Kamei T Asahara M Ochi, Spine (Phila Pa 1976) 2009 34 249 254 19148043
47. Spinal cord injury-induced expression of the antiangiogenic endostatin/collagen XVIII in areas of vascular remodelling. CA Mueller S Conrad HJ Schluesener T Pietsch JM Schwab, J Neurosurg Spine 2007 7 205 214 10.3171/SPI-07/08/205 17688061
48. Influences of the glial environment on the elongation of axons after injury: transplantation studies in adult rodents. AJ Aguayo S David GM Bray, J Exp Biol 1981 95 231 240 7334319
49. Peripheral nerve grafting in the spinal cord: a histological and electrophysiological study. J Wardrope DH Wilson, Paraplegia 1986 24 370 378 3808748
50. Glial influences on axonal growth in the primary olfactory system. R Doucette, Glia 1990 3 433 449 10.1002/glia.440030602 2148546
51. Olfactory bulb ensheathing glia: a unique cell type with axonal growth-promoting properties. A Ramon-Cueto F Valverde, Glia 1995 14 163 173 10.1002/glia.440140302 7591028
52. PNS-CNS transitional zone of the first cranial nerve. R Doucette, J Comp Neurol 1991 312 451 466 10.1002/cne.903120311 1748741
53. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. DD Pearse AR Sanchez FC Pereira CM Andrade R Puzis Y Pressman K Golden BM Kitay B Blits PM Wood MB Bunge, Glia 2007 55 976 1000 10.1002/glia.20490 17526000
54. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. T Takami M Oudega ML Bates PM Wood N Kleitman MB Bunge, J Neurosci 2002 22 6670 6681 12151546
55. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. DJ Barakat SM Gaglani SR Neravetla AR Sanchez CM Andrade Y Pressman R Puzis MS Garg MB Bunge DD Pearse, Cell Transplant 2005 14 225 240 10.3727/000000005783983106 15929557
56. Purification of olfactory nerve ensheathing cells from the olfactory bulb. SC Barnett AM Hutchins M Noble, Dev Biol 1993 155 337 350 10.1006/dbio.1993.1033 7679359
57. Ensheathing cells in the nerve fiber layer of the olfactory bulb - a novel glial cell type. W Wozniak, Folia Morphol (Warsz) 1993 52 121 127 8144096
58. Transplantation of olfactory ensheathing cells or Schwann cells restores rapid and secure conduction across the transected spinal cord. T Imaizumi KL Lankford JD Kocsis, Brain Res 2000 854 70 78 10.1016/S0006-8993(99)02285-4 10784108
59. Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. T Imaizumi KL Lankford WV Burton WL Fodor JD Kocsis, Nat Biotechnol 2000 18 949 953 10.1038/79432 10973214
60. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Y Li PM Field G Raisman, Science 1997 277 2000 2002 10.1126/science.277.5334.2000 9302296
61. Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord, J Neurol Sci 49 (1981) 241-252. ID Duncan AJ Aguayo RP Bunge PM Wood
62. A Systematic Review of Cellular Transplantation Therapies for Spinal Cord Injury, J Neurotrauma. 2010 Apr 20. [Epub ahead of print]. W Tetzlaff EB Okon S Karimi-Abdolrezaee CE Hill JS Sparling JR Plemel WT Plunet EC Tsai D Baptiste LJ Smithson MD Kawaja MG Fehlings BK Kwon
63. Transplantation of Schwann cells to subarachnoid space induces repair in contused rat spinal cord. M Firouzi P Moshayedi H Saberi H Mobasheri F Abolhassani I Jahanzad M Raza, Neurosci Lett 2006 402 66 70 10.1016/j.neulet. 2006.03.070 16644115
64. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. G Garcia-Alias R Lopez-Vales J Fores X Navarro E Verdu, J Neurosci Res 2004 75 632 641 10.1002/jnr.20029 14991839
65. Schwann cell transplantation for repair of the adult spinal cord. M Oudega XM Xu, J Neurotrauma 2006 23 453 467 10.1089/neu.2006.23.453 16629629
66. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. A Abdel-Latif R Bolli IM Tleyjeh VM Montori EC Perin CA Hornung EK Zuba-Surma M Al-Mallah B Dawn, Arch Intern Med 2007 167 989 997 10.1001/archinte.167.10.989 17533201
67. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. M Pai D Zacharoulis MN Milicevic S Helmy LR Jiao N Levicar P Tait M Scott SB Marley K Jestice M Glibetic D Bansi SA Khan D Kyriakou C Rountas A Thillainayagam JP Nicholls S Jensen JF Apperley MY Gordon NA Habib, Am J Gastroenterol 2008 103 1952 1958 10.1111/j.1572-0241.2008.01993.x 18637092
68. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. G Furst J Schulte am Esch LW Poll SB Hosch LB Fritz M Klein E Godehardt A Krieg B Wecker V Stoldt M Stockschlader CF Eisenberger U Modder WT Knoefel, Radiology 2007 243 171 179 10.1148/radiol. 2431060625 17312278
69. Bone marrow-derived aldehyde dehydrogenase-bright stem and progenitor cells for ischemic repair. LH Keller, Congest Heart Fail 2009 15 202 206 10.1111/j.1751-7133.2009.00101.x 19627297
70. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product. JC Capiod C Tournois F Vitry MA Sevestre S Daliphard T Reix P Nguyen JJ Lefrere B Pignon, Vox Sang 2009 96 256 265 10.1111/j.1423-0410. 2008.01138.x 19207166
71. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. K Kemp K Hares E Mallam KJ Heesom N Scolding A Wilkins, J Neurochem 2010 114 6 1569 80 10.1111/j.1471-4159.2009.06553.x 20028455
72. Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment. SS An HL Jin KN Kim HA Kim DS Kim J Cho ML Liu JS Oh DH Yoon MH Lee Y Ha, Childs Nerv Syst 2010 26 3 323 31 10.1007/s00381-009-1040-2 20183925
73. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. CT van Velthoven A Kavelaars F van Bel CJ Heijnen, Brain Behav Immun 2009 19883750
74. Effect of bone marrow-derived mononuclear cells on nerve regeneration in the transection model of the rat sciatic nerve. RK Goel V Suri A Suri C Sarkar S Mohanty MC Sharma PK Yadav A Srivastava, J Clin Neurosci 2009 16 1211 1217 10.1016/j.jocn.2009.01.031 19596581
75. Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro. J Jiang Z Lv Y Gu J Li L Xu W Xu J Lu J Xu, Neurosci Res 66 46 52 10.1016/j.neures.2009. 09.1711 19808065
76. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. A Glavaski-Joksimovic T Virag QA Chang NC West TA Mangatu MP McGrogan M Dugich-Djordjevic MC Bohn, Cell Transplant 2009 18 801 814 10.3727/ 096368909X470801 19796495
77. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. OE Sigurjonsson MC Perreault T Egeland JC Glover, Proc Natl Acad Sci USA 2005 102 5227 5232 10.1073/pnas.0501029102 15790679
78. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. MB Abrams C Dominguez K Pernold R Reger Z Wiesenfeld-Hallin L Olson D Prockop, Restor Neurol Neurosci 2009 27 307 321 19738324
79. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. DI Jung J Ha BT Kang JW Kim FS Quan JH Lee EJ Woo HM Park, J Neurol Sci 2009 285 67 77 10.1016/j.jns.2009.05.027 19555980
80. Transplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model. Y Chiba S Kuroda K Maruichi T Osanai M Hokari S Yano H Shichinohe K Hida Y Iwasaki, Neurosurgery 2009 64 991 999 discussion 999-1000 10.1227/01.NEU.0000341905.57162.1D 19404159
81. Reduction of cystic cavity, promotion of axonal regeneration and sparing, and functional recovery with transplanted bone marrow stromal cell-derived Schwann cells after contusion injury to the adult rat spinal cord. Y Someya M Koda M Dezawa T Kadota M Hashimoto T Kamada Y Nishio R Kadota C Mannoji T Miyashita A Okawa K Yoshinaga M Yamazaki, J Neurosurg Spine 2008 9 600 610 10.3171/SPI.2008.9.08135 19035756
82. Nascimento Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. F Callera RX do, Exp Hematol 2006 34 130 131 10.1016/j.exphem.2005.11.006 16459180
83. Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. JD Steeves JK Kramer JW Fawcett J Cragg DP Lammertse AR Blight RJ Marino JF Ditunno Jr WP Coleman FH Geisler J Guest L Jones S Burns M Schubert HJ van Hedel A Curt, Spinal Cord 2010
84. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. HC Park YS Shim Y Ha SH Yoon SR Park BH Choi HS Park, Tissue Eng 2005 11 913 922 10.1089/ten.2005.11.913 15998231
85. Neurogenic differentiation of murine adipose derived stem cells transfected with EGFP in vitro. Z Fang Q Yang W Xiong G Li J Xiao F Guo F Li A Chen, J Huazhong Univ Sci Technolog Med Sci 30 75 80 10.1007/s11596-010-0113-5 20155459
86. Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. JS Oh Y Ha SS An M Khan WA Pennant HJ Kim H Yoon do M Lee KN Kim, Neurosci Lett 472 215 219 10.1016/j.neulet.2010.02.008 20153400
87. The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs. B Wang J Han Y Gao Z Xiao B Chen X Wang W Zhao J Dai, Neurosci Lett 2007 421 191 196 10.1016/j.neulet.2007. 04.081 17574753
88. Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. HH Ryu JH Lim YE Byeon JR Park MS Seo YW Lee WH Kim KS Kang OK Kweon, J Vet Sci 2009 10 273 284 10.4142/jvs.2009.10.4.273 19934591
89. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. FJ Cao SQ Feng, Chin Med J (Engl) 2009 122 225 231 19187651
90. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. CC Yang YH Shih MH Ko SY Hsu H Cheng YS Fu, PLoS One 2008 3 3336 10.1371/journal.pone.0003336 18852872
91. Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. L Zhang HT Zhang SQ Hong X Ma XD Jiang RX Xu, Neurochem Res 2009 34 2030 2039 10.1007/s11064-009-9992-x 19462232
92. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. KS Kang SW Kim YH Oh JW Yu KY Kim HK Park CH Song H Han, Cytotherapy 2005 7 368 373 10.1080/14653240500238160 16162459
93. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. ZM Zhao HJ Li HY Liu SH Lu RC Yang QJ Zhang ZC Han, Cell Transplant 2004 13 113 122 15129757
94. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. Y Nishio M Koda T Kamada Y Someya K Yoshinaga S Okada H Harada A Okawa H Moriya M Yamazaki, J Neurosurg Spine 2006 5 424 433 10.3171/spi.2006.5. 5.424 17120892
95. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. CH Kao SH Chen CC Chio MT Lin, Shock 2008 29 49 55 17666954
96. Transplants of embryonic motoneurones to adult spinal cord: survival and innervation abilities. G Clowry K Sieradzan G Vrbova, Trends Neurosci 1991 14 355 357 10.1016/0166-2236(91)90162-N 1721741
97. Transplantation of embryonic neurones to replace missing spinal motoneurones. A Nogradi A Szabo, Restor Neurol Neurosci 2008 26 215 223 18820412
98. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. H Takeuchi A Natsume T Wakabayashi C Aoshima S Shimato M Ito J Ishii Y Maeda M Hara SU Kim J Yoshida, Neurosci Lett 2007 426 69 74 10.1016/j.neulet.2007.08.048 17884290
99. Homologous transplantation of neural stem cells to the injured spinal cord of mice. R Pallini LR Vitiani A Bez P Casalbore F Facchiano V Di Giorgi Gerevini ML Falchetti E Fernandez G Maira C Peschle E Parati, Neurosurgery 2005 57 1014 1025 discussion 1014-1025 10.1227/01.NEU.0000180058.58372.4c 16284571
100. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. YI Tarasenko J Gao L Nie KM Johnson JJ Grady CE Hulsebosch DJ McAdoo P Wu, J Neurosci Res 2007 85 47 57 10.1002/jnr.21098 17075895
101. Transplantation of human neural stem cells for spinal cord injury in primates. A Iwanami S Kaneko M Nakamura Y Kanemura H Mori S Kobayashi M Yamasaki S Momoshima H Ishii K Ando Y Tanioka N Tamaoki T Nomura Y Toyama H Okano, J Neurosci Res 2005 80 182 190 10.1002/jnr.20436 15772979 (Pubitemid 40676302)
102. Okano Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury. K Watanabe M Nakamura A Iwanami Y Fujita Y Kanemura Y Toyama H Okano, Dev Neurosci 2004 26 275 287 10.1159/000082144 15711067
103. Xenotransplantation of stem/progenitor cells from human fetal brain to adult rats with spinal trauma. GA Stepanov DO Karpenko MA Aleksandrova OV Podgornyi RA Poltavtseva AV Pevishchin MV Marey GT Sukhikh, Bull Exp Biol Med 2003 135 397 400 10.1023/A:1024633403155 12910319
104. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. N Amariglio A Hirshberg BW Scheithauer Y Cohen R Loewenthal L Trakhtenbrot N Paz M Koren-Michowitz D Waldman L Leider-Trejo A Toren S Constantini G Rechavi, PLoS Med 2009 6 1000029 10.1371/journal.pmed. 1000029
105. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. MY Macias MB Syring MA Pizzi MJ Crowe AR Alexanian SN Kurpad, Exp Neurol 2006 201 335 348 10.1016/j.expneurol.2006.04.035 16839548
106. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. M Hatami NZ Mehrjardi S Kiani K Hemmesi H Azizi A Shahverdi H Baharvand, Cytotherapy 2009 11 618 630 10.1080/14653240903005802 19548142
107. Repair of Spinal Cord Injury by Co-Transplantation of embryonic Stem Cell-Derived Motor Neuron and Olfactory Ensheathing Cell. M Salehi P Pasbakhsh M Soleimani M Abbasi G Hasanzadeh MH Modaresi A Sobhani, Iran Biomed J 2009 13 125 135 19688018
108. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. RM Okamura J Lebkowski M Au CA Priest J Denham AS Majumdar, J Neuroimmunol 2007 192 134 144 10.1016/j.jneuroim.2007.09.030 17996308
109. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. F Cloutier MM Siegenthaler G Nistor HS Keirstead, Regen Med 2006 1 469 479 10.2217/17460751.1.4.469 17465839
110. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells. J Couzin, Science 2009 323 568 10.1126/science.323.5914.568 19179496
111. Geron's IND for Spinal Cord Injuries Placed on Hold. http://www.geron. com/investors/factsheet/pressview.aspx?id=1187
112. Genzyme backs Osiris, despite Prochymal flop. M Allison, Nat Biotechnol 2009 27 966 967 10.1038/nbt1109-966 19898434
113. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. WZ Yang Y Zhang F Wu WP Min B Minev M Zhang XL Luo F Ramos TE Ichim NH Riordan X Hu, J Transl Med 8 75 10.1186/1479-5876-8- 75 20682053
114. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. TE Ichim F Solano R Brenes E Glenn J Chang K Chan NH Riordan, Reprod Biomed Online 2008 16 898 905 10.1016/S1472-6483(10)60159-9 18549704
115. Spinal circuitry and respiratory recovery following spinal cord injury. MA Lane KZ Lee DD Fuller PJ Reier, Respir Physiol Neurobiol 2009 169 123 132 10.1016/j.resp.2009.08.007 19698805
116. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. JW Fawcett A Curt JD Steeves WP Coleman MH Tuszynski D Lammertse PF Bartlett AR Blight V Dietz J Ditunno BH Dobkin LA Havton PH Ellaway MG Fehlings A Privat R Grossman JD Guest N Kleitman M Nakamura M Gaviria D Short, Spinal Cord 2007 45 190 205 10.1038/sj.sc.3102007 17179973 (Pubitemid 46340848)